SMARCB1 and epithelioid sarcoma: Complete INI-1 (SMARCB1) loss has been implicated in both pediatric and adult mesenchymal tumors, with pediatric malignant rhabdoid tumors (MRTs) and epithelioid sarcomas serving as prototypical examples (19).